N-ETHYLLIDOCAINE BROMIDE
中文名称 | N-ETHYLLIDOCAINE BROMIDE |
---|---|
中文同义词 | 化合物 T16707;QX 314 溴化物 |
英文名称 | N-ETHYLLIDOCAINE BROMIDE |
英文同义词 | 2-[(2,6-DIMETHYLPHENYL)AMINO]-N,N,N-TRIETHYL-2-OXO-ETHANAMINIUM BROMIDE;N-ETHYLLIDOCAINE BROMIDE;[2-(2,6-dimethylanilino)-2-oxoethyl]-triethylazanium:bromide;QX 314 bromide,QX314 bromide |
CAS号 | 24003-58-5 |
分子式 | C16H27BrN2O |
分子量 | 343.31 |
EINECS号 | |
相关类别 | |
Mol文件 | 24003-58-5.mol |
结构式 |
N-ETHYLLIDOCAINE BROMIDE 性质
熔点 | 214-215 °C |
---|---|
储存条件 | Desiccate at RT |
溶解度 | 不溶于乙醇;水中≥10.5 mg/mL; ≥25.55 mg/mL,溶于 DMSO |
形态 | 结晶固体 |
颜色 | 白色 |
水溶解性 | Soluble to 100 mM in water |
sodium channel
QX-314 bromide exerts biphasic effects on transient receptor potential vanilloid subtype 1 channels (TRPV1) in vitro .
QX-314 bromide (1–60 mM) directly activates TRPV1 in a concentration-dependent manner.
QX-314 bromide (≥ 30 mM) produces oocyte membrane blackening and cell death .
QX-314 bromide inhibits calcium currents in hippocampal CA1 pyramidal neurons intracellular, and the low-threshold (T-type) Ca
2+
currents are on average < 10% of control amplitude .
QX-314 bromide shifts the current-voltage relationships (I-Vs) in the positive voltage direction due to the presence of intracellular Br- .
QX-314 bromide (1.6 mg/kg; i.c.) abolishes responses to noxious mechanical and thermal stimuli without motor or tactile deficits when co-treatment with capsaicin.
Animal Model: | Male Sprague-Dawley rats (250-290 g) |
Dosage: | 1.6 mg/kg |
Administration: | Intracutaneous injection |
Result: | Abolished responses to noxious mechanical and thermal stimuli without motor or tactile deficits when co-treatment with capsaicin. |